Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
出版年份 2018 全文链接
标题
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 3, Pages 970-975
出版商
Proceedings of the National Academy of Sciences
发表日期
2018-12-28
DOI
10.1073/pnas.1813582116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca2+Uptake and Promotes Colorectal Oncogenesis
- (2018) Fanxin Zeng et al. CANCER RESEARCH
- BiallelicRIPK1mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation
- (2018) Delphine Cuchet-Lourenço et al. SCIENCE
- The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies
- (2017) Aziz Bousfiha et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity
- (2017) Joanne A. O’Donnell et al. JOURNAL OF IMMUNOLOGY
- Human Monocytes Engage an Alternative Inflammasome Pathway
- (2016) Moritz M. Gaidt et al. IMMUNITY
- RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation
- (2016) Juan Lin et al. NATURE
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- RIP1 Kinase Is an Oncogenic Driver in Melanoma
- (2015) X. Y. Liu et al. CANCER RESEARCH
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- SIFT missense predictions for genomes
- (2015) Robert Vaser et al. Nature Protocols
- ClinVar: public archive of interpretations of clinically relevant variants
- (2015) Melissa J. Landrum et al. NUCLEIC ACIDS RESEARCH
- RIPK1 and RIPK3: critical regulators of inflammation and cell death
- (2015) Kim Newton TRENDS IN CELL BIOLOGY
- RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
- (2015) Kate E. Lawlor et al. Nature Communications
- RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
- (2014) James A. Rickard et al. CELL
- RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
- (2014) Christopher P. Dillon et al. CELL
- RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis
- (2014) Nozomi Takahashi et al. NATURE
- RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
- (2014) Marius Dannappel et al. NATURE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
- (2014) W. J. Kaiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis
- (2014) Justine E. Roderick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
- (2013) Kevin Goudy et al. CLINICAL IMMUNOLOGY
- Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
- (2013) Dimitry Ofengeim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Functional complementation between FADD and RIP1 in embryos and lymphocytes
- (2011) Haibing Zhang et al. NATURE
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
- (2009) Erik-Oliver Glocker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More